Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis
出版年份 2023 全文链接
标题
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis
作者
关键词
-
出版物
CURRENT OPINION IN UROLOGY
Volume 33, Issue 6, Pages 472-481
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-09-25
DOI
10.1097/mou.0000000000001132
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia
- (2022) Eleanor L. Watts et al. INTERNATIONAL JOURNAL OF CANCER
- The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications
- (2022) Rajendra Kumar et al. Nature Reviews Urology
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. PLOS MEDICINE
- Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
- (2021) Paula Kappler et al. Scientific Reports
- Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada
- (2021) Christopher J. D. Wallis et al. Cancers
- Does Baseline Serum Testosterone Influence Androgen Deprivation Therapy Outcomes in Hormone Naïve Advanced Prostate Cancer Patients?
- (2020) Anup Patel JOURNAL OF UROLOGY
- Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer
- (2018) Masaki Shiota et al. ANDROLOGIA
- Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy
- (2016) Alexandre de la Taille et al. BJU INTERNATIONAL
- Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
- (2016) Eberhard Varenhorst et al. Cancer Medicine
- Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
- (2015) Abraham Morgentaler et al. ASIAN JOURNAL OF ANDROLOGY
- The Relationship between Total Testosterone Levels and Prostate Cancer: A Review of the Continuing Controversy
- (2015) Julia Klap et al. JOURNAL OF UROLOGY
- Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia
- (2012) Eduard García-Cruz et al. BJU INTERNATIONAL
- Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy
- (2012) A. Salonia et al. CLINICAL CANCER RESEARCH
- Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial
- (2012) Roberto L. Muller et al. EUROPEAN UROLOGY
- Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer
- (2011) Oscar B. Goodman et al. Clinical Genitourinary Cancer
- Low serum testosterone levels are predictive of prostate cancer
- (2011) Luigi Mearini et al. WORLD JOURNAL OF UROLOGY
- Effect of Dutasteride on the Risk of Prostate Cancer
- (2010) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging
- (2009) Phillip M. Pierorazio et al. BJU INTERNATIONAL
- Prognostic grouping of metastatic prostate cancer using conventional pretreatment prognostic factors
- (2009) Arto Mikkola et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started